Cargando…

Chemo-Immunotherapy with Oxaliplatin and Interleukin-7 Inhibits Colon Cancer Metastasis in Mice

Combination of immunotherapy and chemotherapy has shown promise for cancer. Interleukin-7 (IL-7) can potentially enhance immune responses against tumor, while oxaliplatin (OXP), a platinum-based drug, can promote a favorable immune microenvironment and stimulate anticancer immune responses. We evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gou, Hong-Feng, Huang, Juan, Shi, Hua-Shan, Chen, Xin-chuan, Wang, Yong-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897491/ https://www.ncbi.nlm.nih.gov/pubmed/24465710 http://dx.doi.org/10.1371/journal.pone.0085789

Ejemplares similares

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
por: García-Aranda, Marilina, et al.
Publicado: (2018)

Chemo-photothermal immunotherapy for eradication of orthotopic tumors and inhibition of metastasis by intratumoral injection of polydopamine versatile hydrogels
por: Zhuang, Bo, et al.
Publicado: (2022)

Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells
por: Shi, Ying, et al.
Publicado: (2016)

Interleukin 7 Transgenic Mice Develop Chronic Colitis with Decreased Interleukin 7 Protein Accumulation in the Colonic Mucosa
por: Watanabe, Mamoru, et al.
Publicado: (1998)

The Changing Face of Lung Cancer: Oligometastatic Renal Metastasis Post Chemo-Immunotherapy Combination
por: Matini, Elvis, et al.
Publicado: (2023)

Exploiting metabolic inhibition to eradicate residual tumors after chemo-immunotherapy
por: Habtetsion, Tsadik, et al.
Publicado: (2014)

Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice
por: Yiang, Giou-Teng, et al.
Publicado: (2009)

Chemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots)
por: Ektate, Kalyani, et al.
Publicado: (2018)

Nano Ultrasound Contrast Agent for Synergistic Chemo‐photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis
por: Qiu, Yijie, et al.
Publicado: (2023)

Role of oxidative stress in oxaliplatin‐induced enteric neuropathy and colonic dysmotility in mice
por: McQuade, Rachel M, et al.
Publicado: (2016)

The need to optimize chemotherapy regimens for chemo-immunotherapy
por: Inamura, Kentaro, et al.
Publicado: (2022)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

Dramatic response of metaplastic breast cancer to chemo-immunotherapy
por: Adams, Sylvia
Publicado: (2017)

A mathematical model for treatment using chemo-immunotherapy
por: Nave, Ophir
Publicado: (2022)

Chemo-Immunotherapy: A New Trend in Cancer Treatment
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2023)

Litchi procyanidins inhibit colon cancer proliferation and metastasis by triggering gut-lung axis immunotherapy
por: Yao, Yuan, et al.
Publicado: (2023)

Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis
por: Vo, Jimmy LN, et al.
Publicado: (2015)

KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
por: Lin, Yu-Lin, et al.
Publicado: (2012)

Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice
por: Yip, Kwan-Ling, et al.
Publicado: (2022)

A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrence
por: He, Tao, et al.
Publicado: (2023)

Effects of oxaliplatin on mouse myenteric neurons and colonic motility
por: Wafai, Linah, et al.
Publicado: (2013)

Oxaliplatin and infliximab synergize to induce regression of colon cancer
por: Huang, Di, et al.
Publicado: (2018)

Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy
por: Zhou, Xiaogang, et al.
Publicado: (2021)

AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes
por: Shan, Baocong, et al.
Publicado: (2020)

Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells
por: Yu, Peng-Cheng, et al.
Publicado: (2022)

Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.
por: Thatcher, N., et al.
Publicado: (1977)

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
por: Liang, Jingjing, et al.
Publicado: (2020)

Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?
por: Melief, Cornelis J.M.
Publicado: (2022)

Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
por: Wang, Hua, et al.
Publicado: (2020)

Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling
por: Hsu, Hui-Ping, et al.
Publicado: (2017)

PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells
por: Yan, Siyuan, et al.
Publicado: (2019)

Oxaliplatin for Metastatic Colon Cancer in a Patient with Renal Failure
por: Katsumata, Kenji, et al.
Publicado: (2008)

Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada
por: Attard, C.L., et al.
Publicado: (2010)

Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer
por: To, Kenneth K.W., et al.
Publicado: (2016)

Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression
por: Li, Wenya, et al.
Publicado: (2017)

Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell
por: Lei, Guoqiong, et al.
Publicado: (2021)

Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases
por: Ina, Kenji, et al.
Publicado: (2016)

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Time to Retire?
por: Scarfò, Lydia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lkivelbp19uakri0gd4564vi2d